novo nordisk is cutting prices on its popular glp-1 drugs. cuts Wegovy price by up to 37% in India Pharmaceutical giant Novo Nordisk said
Description
These results represent a clinically relevant discovery, pointing to diminishing efficacy of exenatide in patients who develop high titers of emergent-treatment antibodies
While the specific mechanism causing the effects on the gastrointestinal tract are not fully elucidated, studies suggest GLP-1 and its analogues likely exert effects on the vagus nerve and inhibit cholinergic neurotransmission in the gastrointestinal system to prevent movement of the intestine
71 KomatsuR.MatsuyamaT.NambaM.WatanabeN.ItohH.KonoN.et al

6), and the Guizhou Association for Science and Technology 2025XZQYXM-01-03